000 | 03243nam a22003737a 4500 | ||
---|---|---|---|
008 | 230316s20232023 xxu||||| |||| 00| 0 eng d | ||
022 | _a0270-9139 | ||
024 | _a01515467-990000000-00284 [pii] | ||
024 | _a10.1097/HEP.0000000000000267 [doi] | ||
040 | _aOvid MEDLINE(R) | ||
650 | _aIN PROCESS -- NOT YET INDEXED | ||
099 | _a36651183 | ||
245 | _aMulti-Centered study of patient outcomes after declined for early liver transplantation in severe Alcohol-associated hepatitis. | ||
251 | _aHepatology. 2023 Jan 19 | ||
252 | _aHepatology. 2023 Jan 19 | ||
253 | _aHepatology (Baltimore, Md.) | ||
260 | _c2023 | ||
260 | _fFY2023 | ||
260 | _p2023 Jan 19 | ||
265 | _saheadofprint | ||
265 | _tPublisher | ||
520 | _aBACKGROUND: Early liver transplantation (LT) for alcohol-associated hepatitis (AH) is controversial in part because patients may recover, and obviate the need for LT. | ||
520 | _aCONCLUSIONS: Liver recompensation is infrequent among severe AH patients declined for LT. Higher MELD-Na and age were associated with short-term mortality, while only history of failed alcohol rehabilitation was associated long-term mortality. The distinction between survival and liver recompensation merits further attention. Copyright © 2023 American Association for the Study of Liver Diseases. | ||
520 | _aMETHODS: In this retrospective study among 5 ACCELERATE-AH sites, we randomly sampled patients evaluated and then declined for LT for AH. All had MELD>20 and<6 months of abstinence. Recompensation was defined as MELD<15 without variceal bleeding, ascites or overt hepatic encephalopathy requiring treatment. Multi-level mixed effects linear regression was used to calculate probabilities of recompensation; multivariable Cox regression was used for mortality analyses. | ||
520 | _aRESULTS: Among 145 patients (61% men; median abstinence time and MELD-Na was 33 days [IQR 13-70] and 31 [IQR 26-36], respectively), 56% were declined for psychosocial reasons. Probability of 30-day, 90-day, 6-month, and 1-year survival were 76% (95%CI: 68-82%), 59% (95%CI: 50-66%), 49% (95%CI: 40-57%), and 46% (95%CI: 37-55%), respectively. Probability of 1-year recompensation was low at 10.0% (95%CI: 4.5-15.4%). Among patients declined due to clinical improvement, 1-year probability of recompensation was 28.0% (95%CI: 5.7-50.3%). Among survivors, median MELD-Na at 30-days, 90-days, and 1-year were: 29 (IQR 22-38), 19 (IQR 14-29), and 11 (IQR 7-17). Increased MELD-Na (aHR1.13, P<0.001) and age (aHR1.03, P<0.001) were associated with early (<=90 d) death, and only history of failed alcohol rehabilitation (aHR1.76, P=0.02) was associated with late death. | ||
546 | _aEnglish | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aOphthalmology Residency | ||
657 | _aJournal Article | ||
700 |
_aDavis, William _bMWHC _cOphthalmology Residency _dMD _eResident PGY 3 |
||
790 |
_aHsu CC _aDodge JL _aWeinberg E _aIm G _aKo J _aDavis W _aRutledge S _aDukewich M _aShoreibah M _aAryan M _aVosooghi A _aLucey M _aRice J _aTerrault NA _aLee BP |
||
856 |
_uhttps://dx.doi.org/10.1097/HEP.0000000000000267 _zhttps://dx.doi.org/10.1097/HEP.0000000000000267 |
||
942 |
_cART _dJournal Article |
||
999 |
_c11401 _d11401 |